JPRN-UMIN000002458已完成2 期
Prospective study of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer without pathologic confirmation - Prospective study of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer without pathologic confirmation
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 65
研究概览
简要总结
With a median follow-up period of 55 months, the 3-year overall survival rate was 83% (95%CI:71-91%). Grade 3 and 4 chronic adverse event was experienced in 8 and 1 patients, respectively.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Apparent interstitial pneumonia on chest X-ray. 2) Patinets with active infectious disease. 3) Patients with active other cancers. 4) Pregnant patients. 5) Patients with psychiatric disorders and unable to participate the study. 6) Patients now treated by steroids. 7) Patients who need oxygen inhalation. 8) Fever up.
研究者
相似试验
终止
2 期
Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver TransplantationHepatobiliary NeoplasmBile Duct CancerCancer of GallbladderLiver CancerCholangiocarcinomaNCT01151761Stanford University2
终止
3 期
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)Non-Small Cell Lung CancerNCT03924869Merck Sharp & Dohme LLC448
撤回
不适用
Surgery Versus Stereotactic Body Radiation Therapy for Stage up to IA2 (T1a or T1b) Non-small Cell Lung CancerNon-small Cell Lung Cancer Stage ISurgeryStereotactic Body Radiation TherapyNCT03431415Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
招募中
3 期
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate CancerNCT05946213NRG Oncology1,209
招募中
3 期
Systemic Therapy Alone or With Stereotactic Body Radiotherapy for Oligometastatic Kidney Cancer (STROKER Study)Renal Cell Carcinoma (Kidney Cancer)Kidney Cancer MetastaticRenal Cell Carcinoma MetastaticNCT06726421Sun Yat-sen University252